$3.4 Billion Worldwide Blood Transfusion Diagnostics Industry to 2027 - Impact of COVID-19 on the Market

DUBLIN, Dec. 4, 2020 /PRNewswire/ -- The "Blood Transfusion Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

The publisher brings years of research experience to the 6th edition of this report. The 372-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Global Blood Transfusion Diagnostics Market to Reach $4.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Blood Transfusion Diagnostics estimated at US$3.4 Billion in the year 2020, is projected to reach a revised size of US$4.7 Billion by 2027, growing at a CAGR of 4.8% over the period 2020-2027.

Instruments, one of the segments analyzed in the report, is projected to record 4.4% CAGR and reach US$1.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Kits & Reagents segment is readjusted to a revised 5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $912.8 Million, While China is Forecast to Grow at 7.2% CAGR

The Blood Transfusion Diagnostics market in the U.S. is estimated at US$912.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$944.2 Million by the year 2027 trailing a CAGR of 7.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 4.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Competitors identified in this market include, among others:

• Abbott Laboratories
• Bag Health Care GmbH
• Bio-Rad Laboratories, Inc.
• DiaSorin SpA
• F. Hoffmann-La Roche AG
• Grifols International SA
• Hologic, Inc.
• Immucor, Inc.
• Ortho Clinical Diagnostics, Inc.
• Quotient Ltd.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Global Competitor Market Shares
• Blood Transfusion Diagnostics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

• Total Companies Profiled: 42

For more information about this report visit https://www.researchandmarkets.com/r/rd9fld

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/3-4-billion-worldwide-blood-transfusion-diagnostics-industry-to-2027---impact-of-covid-19-on-the-market-301186541.html

SOURCE Research and Markets